D. Sulitzeanu

发表

Immunization against Brucella with killed vaccines. Immunizing activity in mice of Brucella cell walls and of fractions derived from them.

G. Rasooly, A. Olitzki, D. Sulitzeanu, 1966, Israel journal of medical sciences.

Antigen processing and presentation by EBV‐carrying cell lines: Cell‐phenotype dependence and influence of the EBV‐encoded LMP1

G. Klein, D. Sulitzeanu, S. Torsteinsdottir, 1993, International journal of cancer.

Detection of an Epstein-Barr virus-associated membrane antigen in Epstein-Barr virus-transformed nonproducer cells by leukocyte migration inhibition and blocking antibody.

G. Klein, W. Henle, G. Henle, 1984, Proceedings of the National Academy of Sciences of the United States of America.

Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.

E. Kieff, J. Dillner, O. Weiland, 1986, Clinical immunology and immunopathology.

Leukocyte migration inhibition demonstrates a human T-cell response to a membrane protein expressed in latent Epstein-Barr virus infection

E. Kieff, G. Klein, K. Hennessy, 1986, Journal of Virology.

Immunosuppressive factors in human cancer.

D. Sulitzeanu, 1993, Advances in cancer research.

Immunological studies on the L-glutamic acid decarboxylase from Escherichia coli K-12.

D. Sulitzeanu, Y. S. Halpern, M. Lupo, 1969, Archives of biochemistry and biophysics.

Degenerative changes in the A375 melanoma line induced by transforming growth factor beta 1.

D. Sulitzeanu, S. Larisch-Bloch, R. Yarom, 1992, Immunology letters.

Affinity of antigen for white cells and its relation to the induction of antibody formation.

D. Sulitzeanu, 1968, Bacteriological reviews.

Affinity of antigen for white cells and its relation to the induction of antibody formation

D. Sulitzeanu, 1968 .

Coexistence in human sera of a cell (membrane?) ANTIGEN AND Of autoantibodies directed against it.

G. Klein, D. Sulitzeanu, Y. Gorsky, 2008, Tissue antigens.

Anti-red blood cell autoantibodies induced in rat by Plasmodium berghei infection bind to a cross-reacting determinant present also in other cell types.

Z. Ronai, D. Sulitzeanu, 1983, Clinical immunology and immunopathology.

Single and double stranded DNA binding lymphocytes in the peripheral blood of patients with systemic lupus erythematosus and normal controls.

S. Slavin, D. Sulitzeanu, 1979, Annals of the rheumatic diseases.

Morphologic evidence suggestive of host-tumor cell interactions in vivo in human cancer patients.

S. Paglin, D. Sulitzeanu, D. Weiss, 1974, Journal of the National Cancer Institute.

A technique for the purification of immune complexes using rheumatoid factor.

D. Sulitzeanu, Z. Gilead, 1979, Journal of immunological methods.

Cross-reactivity between the EBNA-1 p107 peptide, collagen, and keratin: implications for the pathogenesis of rheumatoid arthritis.

G. Klein, D. Sulitzeanu, P. Birkenfeld, 1990, Clinical immunology and immunopathology.

Proteins in normal and malignant cells, cross‐reacting with the latent membrane protein encoded by Epstein‐Barr virus

R. Lerner, G. Klein, A. Hatzubai, 1988, European journal of immunology.

Isolation and electrophoretic analysis of immune complexes from patients with breast cancer.

D. Sulitzeanu, Z. Gilead, F. Troy, 1981, European journal of cancer & clinical oncology.

Antigenic components of rat connective tissue.

D. Sulitzeanu, 1965, British journal of experimental pathology.

Human cancer-associated antigens: present status and implications for immunodiagnosis.

D. Sulitzeanu, 1985, Advances in cancer research.

Isotopic Determination of Vitamin B12 Binding Capacity and Concentration.∗

D. Sulitzeanu, N. Grossowicz, D. Merzbach, 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

The assay of penicillin in blood-serum using Sarcina lutea.

D. Sulitzeanu, J. Lightbown, 1957, Bulletin of the World Health Organization.

The participation of thymus‐derived and of bone marrow‐derived lymphocytes of sensitized mice, in the proliferative response to specific antigen, in vitro

I. Gery, D. Sulitzeanu, Lea Mugraby, 1974, European journal of immunology.

A radioactive antibody binding-inhibition assay, for the detection of cell-membrane related antigens in body fluids.

D. Sulitzeanu, Y. Gorsky, 1975, Journal of immunological methods.

Studies on the mechanism of non-specific resistance to Brucella induced in mice by vaccination with BCG.

D. Sulitzeanu, A. Bekierkunst, J. Loebel, 1962, Immunology.

Distribution of Radioiodinated, Acetone-killed Brucella abortus in the Tissues of Normal and Immune Mice

D. Sulitzeanu, 1958, Nature.

Purification of antibodies to membrane antigens of hamster cells transformed by sv40 and binding of the radioiodinated, purified antibodies to intact cells

E. Kedar, N. Goldblum, D. Sulitzeanu, 1972, International journal of cancer.

Antigens in immune complexes from patients with breast cancer

A. Hatzubai, D. Sulitzeanu, Z. Gilead, 1982, Cancer Immunology, Immunotherapy.

LAK cells release a novel form of directly acting TGF beta, tightly bound to a high molecular weight carrier(s).

D. Sulitzeanu, S. Larisch-Bloch, Dov Sulitzeanu, 1993, Growth factors.

Mechanism of Immunity Against Brucella

D. Sulitzeanu, 1965, Nature.

Immunogenic activity of Brucella cell wall.

J. Markenson, A. Olitzki, D. Sulitzeanu, 1962, British journal of experimental pathology.

The fate of killed, radioiodinated Brucella abortus injected into mice.

D. Sulitzeanu, 1959, Journal of immunology.

Passive Protection Experiments with Brucella Antisera

D. Sulitzeanu, 1955, Journal of Hygiene.

The use of streptomycin-resistant and nonresistant strains for the determination of the immunizing effect of living Brucella abortus vaccines in white mice.

A. Olitzki, D. Sulitzeanu, 1954, Journal of Infectious Diseases.

Induced Resistance of Mice to Infection with Brucella abortus 2308 through Vaccination with BCG

D. Sulitzeanu, A. Bekierkunst, 1958, Nature.

Observations on men vaccinated with a streptomycin dependent Brucella strain.

G. Rasooly, A. Olitzki, D. Sulitzeanu, 1960, The Journal of infectious diseases.

[Local and general reaction and antibody production in volunteers after the administration of living streptomycin-dependent Brucellae].

A. Olitzki, D. Sulitzeanu, 1953, Harefuah.

Relationship of agar diffusion patterns to agglutinating and protective properties of Brucella suis antisera.

D. Sulitzeanu, 1958, British journal of experimental pathology.

Immunizing Properties of Insoluble Cell Material derived from Brucella

J. Markenson, A. Olitzki, D. Sulitzeanu, 1959, Nature.

Localization of Radioactivity in Tumours of Mice injected intravenously with Killed, Radioiodinated Brucella abortus

D. Sulitzeanu, 1960, Nature.

An Immunogenic Fraction extracted from Brucella abortus Cell Wails by Phenol

G. Rasooly, A. Olitzki, D. Sulitzeanu, 1965, Nature.

The fate of killed, raioiodinated Brucella abortus injected into mice. II. Mechanism determining the distribution of the injected bacteria.

D. Sulitzeanu, O. Sperling, A. Bdolach, 1960, Journal of immunology.

EBV, molecular mimicry and rheumatoid arthritis: a hypothesis.

D. Sulitzeanu, M. Anafi, 1989, Immunology letters.

Simplified technique for preparative disc electrophoresis. II. Further improvements in apparatus and some details of performance.

D. Sulitzeanu, M. Slavin, E. Yecheskeli, 1967, Analytical biochemistry.

Simplified Technique for Preparative Disc Electrophoresis

D. Sulitzeanu, W. F. Goldman, 1965, Nature.

Isolation from patients with breast cancer of antibodies specific for antigens associated with breast cancer and other malignant diseases.

D. Sulitzeanu, F. Vánky, Y. Gorsky, 1976, Proceedings of the National Academy of Sciences of the United States of America.

A high molecular weight cytotoxic lymphokine in supernatants of lymphokine-activated killer cells cross-reacts with transforming growth factor beta.

D. Sulitzeanu, S. Larisch-Bloch, B. Sterman, 1990, Immunology letters.

Antigenic changes on the surface of lymphocytes from patients with chronic lymphocytic leukemia.

D. W. Weiss, Z. Bentwich, E. Kedar, 1972, Cancer research.

The affinity of radioiodinated BSA for lymphoid cells. II. Binding of 125I-BSA to lymphoid cells of normal mice.

D. Naor, D. Sulitzeanu, 1969, International archives of allergy and applied immunology.

Direct conversion of precursors of PFCs into active PFCs in vitro, without prior cell division.

J. Haskill, D. Sulitzeanu, J. Marbrook, 1973, Immunology.

Culture supernatants of lymphokine-activated killer (LAK) cells contain a high-molecular-weight cytotoxic lymphokine.

D. Sulitzeanu, S. Larisch-Bloch, D. Weiss, 1989, Immunology letters.

Secondary response to bovine serum albumin in diffusion chambers. Stimulation with low doses of antigen.

D. Sulitzeanu, M. Birnbaum, 1969, Immunology.

(Auto)antibodies in human breast cancer sera against antigens associated with breast cancer cells, detected by immunoblotting.

Z. Ronai, D. Sulitzeanu, 1986, Journal of the National Cancer Institute.

Streptococci in Dental Caries

D. Sulitzeanu, J. Yardeni, N. Citri, 1959, Journal of dental research.

The Antigenic Structure in the Genus Brucella.

A. Olitzki, D. Sulitzeanu, 1957 .

Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population.

S. T. Liu, Yu Chang, Chi-Neu Tsai, 1992, Oncogene.

Subpopulations of mouse spleen lymphocytes. III. Cellular interactions in the response to concanavalin A.

I. Gery, D. Sulitzeanu, L. Mugraby, 1975, Immunology.

Use of a streptomycin dependent strain of Vibrio comma for quantitative assay of streptomycin.

A. Olitzki, D. Sulitzeanu, 1955, Experimental medicine and surgery.

Soluble Antigens from Rat Liver Connective Tissue.∗

D. Pressman, Y. Yagi, D. Sulitzeanu, 1963, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

Binding of 125I-BSA to lymphoid cells of tolerant mice.

D. Naor, D. Sulitzeanu, 1969, International archives of allergy and applied immunology.

Protective Action of Monospecific Anti-Brucella Sera in Mice

D. Sulitzeanu, L. Jones, A. W. Stableforth, 1955, Nature.

Cellular interactions and the secondary response in vitro.

I. Gery, D. Benezra, D. Sulitzeanu, 1971, Nature: New biology.

SEPARATION OF AN ANTIGENIC FRACTION FROM RAT LIVER RESPONSIBLE FOR THE FORMATION OF LIVER LOCALIZING ANTIBODIES.

D. Pressman, Y. Yagi, D. Sulitzeanu, 1963, Journal of immunology.

LIVER LOCALIZING ANTIBODIES--THE LIMITED CONTRIBUTION OF AG-AB COMPLEXES.

D. Pressman, Y. Yagi, D. Sulitzeanu, 1964, Journal of immunology.

Subpopulations of mouse spleen lymphocytes. I. Dissociation between the reactivities to different "non-specific" mitogens.

I. Gery, D. Sulitzeanu, L. Mugraby, 1974, Immunology.